From: The role of extracellular vesicles in cholangiocarcinoma
The source of EVs | (TEM)/ (NTA) | Biomarkers | References |
---|---|---|---|
CCA bile | Rounded, cup-shaped, double-membrane-bound vesicles, 50–750 nm in diameter | TSG101, ALIX, CD9, HSP70.1 | [42] |
Spherical structures of vesicles,30–110 nm in diameter, the mode of exosomes sizes is 72.2 nm | CD63, CD81 | [99] | |
Spherical structures, the mode of EVs sizes is 84 nm, 30–110 nm in diameter, 3 × 1011 EVs/ml bile | TSG101, CD63 | [98] | |
CCA serum | Round morphology, ~ 180 nm in diameter | CD9, CD63, CD81 | [104] |
50–750 nm in diameter | TSG101, ALIX, CD9, HSP70.1 | [42] | |
KKU-M213 KKU-100 | Crescent shaped membrane invagination, 40–100 nm in diameter | Flotillin-1, TSG101, CD81, CD63 | [64] |
50–150 nm in diameter | Flotillin-1, CD81, TSG101 | [73] | |
KMBC | Spherical structures of vesicles, a mean size of 137 ± 960 nm | ALIX, CD9, CD81 | [61] |
KKU-M213D5 | 40–100 nm in diameter | ALIX, TSG101 | [105] |
RBE | 30–120 nm in diameter | ALIX, TSG101, CD63 | [65] |
HuCCA-1 | 50–150 nm in diameter | Flotillin-1, CD81, TSG101 | [73] |
H69 | 50–150 nm in diameter | Flotillin-1, CD81, TSG101 | [73] |